The active component in Crocin-DS is commonly used across therapeutic domains where short-term symptomatic assistance is needed for pain and fever.

Relief of Acute Febrile Symptoms

Crocin-DS is commonly used to provide supportive symptom management for elevated body temperature (fever), which is a symptom related to systemic imbalance. It may assist with easing pyrexia and the accompanying discomforts of chills and generalized malaise frequently associated with conditions like the common cold and influenza. It supports patients during episodes of heightened discomfort by assisting with easing elevated body temperature (fever) and providing supportive symptom management for general malaise.

Management of Mild to Moderate Pain

The medication is commonly used to help with analgesic relief across a range of mild to moderate pain types that are episodic or temporary. This includes localized symptoms such as headaches, toothache, and the discomfort of a sore throat, as well as general discomforts like musculoskeletal aches and menstrual cramping. Crocin-DS is often applied in clinical settings involving temporary physiological imbalance, such as assisting with the expected transient discomfort following routine immunizations.

Quick Fact: Relief for Acute Discomfort Crocin-DS is commonly used to help manage both pyrexia (fever) and mild to moderate pain, offering support across conditions characterized by systemic or localized discomfort.

Regulatory References

1. National Library of Medicine – MedlinePlus overview on Acetaminophen uses

Official Population Eligibility Status (Acetaminophen)

Official regulatory guidelines define clear eligibility and contraindication criteria for using Crocin-DS (Acetaminophen), primarily based on underlying health status and age.

Contraindications (Must Not Use)

Use of this medicine is absolutely prohibited (contraindicated) for individuals with:

• Known hypersensitivity or allergy to acetaminophen or any component of the formulation.
• Severe active liver disease or severe hepatic impairment.

Conditional and Restricted Use

Specific populations are eligible but require caution or special consideration, as detailed in regulatory labeling:

• Organ Function: Patients with severe renal impairment (creatinine clearance le 30 mL/min) or non-severe hepatic impairment require caution, and dosage intervals may need adjustment.
• Comorbidities: Caution is advised for those with chronic alcoholism, chronic malnutrition, or severe hypovolemia, due to increased risk factors.

Age and Reproductive Status

• Age Groups: The medicine is approved for use across all age ranges, from neonates and infants up to older adults. No overall differences in safety or effectiveness have been observed for geriatric subjects. Products intended for adults must not be given to children under 12.
• Pregnancy/Lactation: Acetaminophen is generally considered suitable for use while breastfeeding. During pregnancy, use is permitted when clinically needed, as it is considered the preferred over-the-counter pain reliever.

Interactions with other medicines and products

This section outlines documented interactions based on official regulatory information for products containing Paracetamol (Acetaminophen).

Documented Interacting Medicines and Categories

Interaction-Related Constraints and Requirements

Use of this product with Oral Anticoagulants (like Warfarin) requires careful monitoring of the anticoagulant effect, as regular daily use over a prolonged period may enhance the risk of bleeding. Occasional use typically has no significant effect.

Co-administration with other products containing Paracetamol is strictly restricted to prevent accidental overdose and the resulting risk of severe liver damage. The consumption of alcohol must be avoided during treatment due to a substantially increased potential for liver toxicity.

Cholestyramine reduces the absorption of Paracetamol, necessitating a minimum two-hour interval between taking this medicine and the resin. Conversely, Prokinetic Agents may increase the speed of Paracetamol absorption. Hepatotoxic agents or enzyme inducers may increase the risk of Paracetamol-induced toxicity, requiring cautious co-administration.

Crocin-DS contains paracetamol (acetaminophen), a substance whose mechanism is primarily centered in the central nervous system (CNS). Its action is mediated through multiple molecular targets.

Central Cyclooxygenase Inhibition

Paracetamol modulates the activity of cyclooxygenase enzymes, particularly an isoform or variant of COX-1 found in the CNS. The molecule acts as a weak inhibitor of prostaglandin (PG) synthesis, which differs from the non-selective peripheral inhibition seen with non-steroidal anti-inflammatory drugs. By reducing CNS prostaglandin E2 (PGE2) levels in the hypothalamus, paracetamol modifies the set-point of the central thermoregulatory pathway, leading to a system-level decrease in core body temperature.

Metabolite-Mediated Pathways

After crossing the blood-brain barrier, paracetamol is metabolized into N-acylphenolamine (AM404). This bioactive metabolite serves as an agonist for the Transient Receptor Potential Vanilloid 1 (TRPV1) receptor, a ligand-gated ion channel, and also acts indirectly on the cannabinoid CB1 receptors. The activation of TRPV1 and the engagement of the endocannabinoid system, coupled with potentiation of the descending serotonergic inhibitory pathways, collectively modulate nociceptive signal transmission in the dorsal horn and midbrain. These intracellular and neuronal network effects result in altered systemic pain perception.

How to Use Crocin-DS (Paracetamol Oral Suspension)

The administration guidelines for Crocin-DS Oral Suspension outline the appropriate use, dosing, timing, and preparation steps required for this pediatric formulation.

Administration and Preparation

Crocin-DS is an Oral Suspension and must be administered exclusively by the oral route (by mouth). Before measuring each dose, the bottle must be shaken well to ensure the medication is properly mixed. The correct volume of medicine must be measured using the dosing cup or device provided with the product to ensure accuracy. The suspension can be taken with or without food.

Dosage and Schedule

Population-Specific Rules

Dosage is determined by the patient's body weight, not solely by age, as outlined for the pediatric population. It is mandatory not to take this product with any other medicine that contains Paracetamol (Acetaminophen) to avoid exceeding the maximum daily dose and to comply with labeled restrictions.

Research evidence / Overview of Studies for Crocin-DS

Evidence for Symptomatic Relief of Fever (Antipyretic Use)

Research has explored the active component in Crocin-DS in the context of fever and outcomes related to systemic or functional imbalance. The evidence base includes Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews that examined what happens to body temperature during periods of increased symptom activity. Findings describe patterns observed in the studies where measurements of body temperature changed during the observation period after administration in various patient groups.

However, when researchers explored major clinical outcomes beyond temperature readings, such as length of hospital stays or observed recovery patterns in critically ill patients, the findings were mixed across studies. This evidence is limited and heterogeneous concerning effects on non-temperature outcomes.

Evidence for Mild to Moderate Acute Pain

The research for outcomes related to physical discomfort (mild to moderate acute pain) is primarily composed of short-term Randomized Controlled Trials (RCTs) and large-scale Systematic Reviews. These studies research examined how symptoms change over time for specific issues like headaches, toothache, and musculoskeletal aches, and studies explored differences in patient-reported outcomes describing perceived discomfort compared to a control or placebo.

Findings describe patterns observed in the studies where patient-reported outcomes describing perceived discomfort were measured over the defined observation intervals. This research provides insight into short-term changes in episodic or acute changes in pain, which is relevant in trials assessing temporary symptom patterns.

Research Gaps and Unanswered Questions

Despite the extensive research conducted, certain areas of uncertainty exist. Evidence quality varies across studies, and the findings were mixed regarding specific major clinical outcomes, particularly in critically ill populations. A major limitation is that the comparative evidence is lacking or inconsistent regarding differences in observed outcomes when compared with other similar agents for various acute conditions. Because of short observation periods, long-term effects are not fully established, and subgroup findings are uncertain in many areas.

Common questions about Crocin-DS (FAQ)

Q: What is Crocin-DS used for?

A: Crocin-DS is indicated to temporarily reduce fever and relieve mild to moderate pain, such as headaches, toothaches, or muscle aches. Indications are based on the product's official regulatory information.

Q: How quickly does Crocin-DS typically start to work?

A: The time it takes for the effects of the medication to be noticeable can vary among individuals. Product labeling suggests that it generally begins to provide relief within a specific time frame, but this is an average and not a guarantee.

Q: Can I give Crocin-DS to my child if they have a virus?

A: This medication is intended for the temporary relief of fever and pain associated with conditions like the common cold or flu. It is important to consult a healthcare provider for the appropriate management of any viral illness, especially in children, and to confirm if this product is suitable.

Q: Is Crocin-DS safe for long-term use?

A: This product is typically intended for short-term use. Using it for an extended period, or using more than the recommended amount, may increase the risk of serious side effects, particularly involving the liver. Consult a healthcare professional if pain or fever persists for more than a few days.

Q: What should I do if I miss a dose?

A: If a dose is missed, it is generally recommended to administer the next dose at the regularly scheduled time. Do not administer extra medication to make up for the missed dose. Always follow the specific instructions provided on the product label or by a healthcare provider.

Storage and Handling Requirements

Crocin-DS Oral Suspension must be stored in its original container at ambient room temperature, or at or below 25 C. To maintain stability and effectiveness, the product should be protected from light and moisture. It is explicitly stated Do not freeze the suspension. For safe administration, the bottle must be shaken well before use.

Child Safety and Disposal

It is essential to keep Crocin-DS out of the sight and reach of children and pets, as the product is supplied with a child-resistant cap. The designated shelf life is 24 months from the date of manufacture. To dispose of unused or expired medicine, regulatory guidance advises against flushing down the toilet. Instead, discard it by mixing it with an undesirable substance (such as used coffee grounds or dirt) and placing the sealed mixture in the household trash, ensuring it is not consumed.